Ledger.Open graph →
SEC Form D · filed February 23, 2023

Lirum Therapeutics, Inc

Offering
$10.0M
Sold
$6.3M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
NEW YORK, NY
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (8)

Daniel Hume · New York, NYDirectorKenneth Hoberman · Fort Lee, NJExec · DirectorMark Sard · New York, NYDirectorIvan Bergstein · New York, NYDirectorDaniel Hume · New York, NYDirectorKenneth Hoberman · Fort Lee, NJExec · DirectorMark Sard · New York, NYDirectorIvan Bergstein · New York, NYDirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗